Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1′,2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having HIV integrase inhibitory activity

US Patent 11267823 · Granted Mar 8, 2022

Estimated economic value: $240,546,000

Assignee

Inventors

View full patent text on Google Patents →